Robert James Connor
21Patents
4h-index
10Co-inventors
56Inventor score
Filing activity: Dec 28, 2012 → Jul 19, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9447401B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 30 | Active |
| US11041149B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 20 | Active |
| US11066656B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 20 | Active |
| US10865400B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US12091692B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US12018298B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11952600B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US12104185B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US12104184B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12152262B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12077791B2 | PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12123035B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12371685B2 | PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12178860B2 | Hyaluronidase enzyme formulations for high volume administration | Chemistry; Metallurgy | 0 | Active |
| US12060590B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12037618B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12195773B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12264345B1 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12110520B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12054758B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12049652B2 | PH20 polypeptide variants, formulations and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.